ONVO Research and Charts

ONVO - Organovo Holdings Inc (Healthcare: Diagnostics & Research)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-04-23)

Last 2.04	Change ⇑ +0.03 (+1.49%)	Volume 243,968
	Open 2.16	High 2.16	Low 1.94

8EMA (Daily) 1.88	40EMA (Daily) 1.55	50EMA (Daily) 1.43	STO (Daily) 34.940	MACD Hist (Daily) -0.088
8EMA (Weekly) 1.688	40EMA (Weekly) 0.97	50EMA (Weekly) 0.95	STO (Weekly) 44.667	MACD Hist (Weekly) 0.284


Company Profile
Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.